首页 > 最新文献

Journal of the Korean Society of Coloproctology最新文献

英文 中文
Recurrent renal leiomyosarcoma mimicking a colonic submucosal tumor: a case report. 模拟结肠粘膜下肿瘤的复发性肾平滑肌肉瘤1例报告。
Pub Date : 2011-10-01 Epub Date: 2011-10-31 DOI: 10.3393/jksc.2011.27.5.270
Yun Jeung Kim, Hee Seok Moon, Eaum Seok Lee, Jae Kyu Sung, Hyun Yong Jeong, Ji Yeon Kim, Dae Young Kang

A primary leiomyosarcoma of the kidney is a rare, but highly aggressive, neoplasm, accounting for only 0.1% of all invasive renal tumors. Local or systemic recurrence is common, but a leiomyosarcoma is difficult to diagnose preoperatively. We recently encountered an interesting case of an unusual recurrence of a renal leiomyosarcoma. A 57-year-old woman visited our hospital complaining of lower abdominal pain. Four years previously, she had undergone a left nephrectomy. She had a primary leiomyosarcoma of the kidney that had been misdiagnosed as a renal cell carcinoma. Colonoscopy revealed the presence of a lesion similar to a submucosal tumor in the descending colon. Postoperative pathologic examination confirmed that the mass was a recurrent leiomyosarcoma. We report this unusual case and present a review of the literature.

原发性肾脏平滑肌肉瘤是一种罕见但具有高度侵袭性的肿瘤,仅占所有侵袭性肾脏肿瘤的0.1%。局部或全身复发是常见的,但平滑肌肉瘤术前很难诊断。我们最近遇到一个有趣的病例,肾脏平滑肌肉瘤不寻常的复发。一名57岁妇女来我院就诊,主诉下腹部疼痛。四年前,她接受了左肾切除术。她患有原发性肾脏平滑肌肉瘤,曾被误诊为肾细胞癌。结肠镜检查发现在降结肠有类似粘膜下肿瘤的病变。术后病理检查证实肿块为复发性平滑肌肉瘤。我们报告这个不寻常的病例,并提出了文献综述。
{"title":"Recurrent renal leiomyosarcoma mimicking a colonic submucosal tumor: a case report.","authors":"Yun Jeung Kim,&nbsp;Hee Seok Moon,&nbsp;Eaum Seok Lee,&nbsp;Jae Kyu Sung,&nbsp;Hyun Yong Jeong,&nbsp;Ji Yeon Kim,&nbsp;Dae Young Kang","doi":"10.3393/jksc.2011.27.5.270","DOIUrl":"https://doi.org/10.3393/jksc.2011.27.5.270","url":null,"abstract":"<p><p>A primary leiomyosarcoma of the kidney is a rare, but highly aggressive, neoplasm, accounting for only 0.1% of all invasive renal tumors. Local or systemic recurrence is common, but a leiomyosarcoma is difficult to diagnose preoperatively. We recently encountered an interesting case of an unusual recurrence of a renal leiomyosarcoma. A 57-year-old woman visited our hospital complaining of lower abdominal pain. Four years previously, she had undergone a left nephrectomy. She had a primary leiomyosarcoma of the kidney that had been misdiagnosed as a renal cell carcinoma. Colonoscopy revealed the presence of a lesion similar to a submucosal tumor in the descending colon. Postoperative pathologic examination confirmed that the mass was a recurrent leiomyosarcoma. We report this unusual case and present a review of the literature.</p>","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6f/29/jksc-27-270.PMC3218133.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30268466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Laparoscopic versus open appendectomy for appendicitis in elderly patients. 老年阑尾炎患者腹腔镜阑尾切除术与开放式阑尾切除术的比较。
Pub Date : 2011-10-01 Epub Date: 2011-10-31 DOI: 10.3393/jksc.2011.27.5.241
Hyun Nam Baek, Yong Hwan Jung, Yong Hee Hwang

Purpose: The appendectomy is the most common emergent surgical procedure in elderly patients. The increasing number of elderly persons has been accompanied by an increase in the number of cases of acute appendicitis in the elderly. In order to understand the clinical significance of a laparoscopic appendectomy for elderly patients with appendicitis, we investigated the results of a laparoscopic appendectomy for treating patients over 60 years of age with appendicitis and compared them with the results for an open technique.

Methods: We studied retrospectively patients over 60 years of age who underwent an appendectomy with either a laparoscopic (LA) or open (OA) technique for appendicitis between July 2007 and December 2009. There were 30 patients in the LA group and 47 patients in the OA group. The demographic data, operative time, length of the hospital stay, bowel movement, pain control, cost, complications and pre-existing disease were assessed.

Results: There were no significant differences between the LA and the OA groups with respect to pre-existing diseases, gender, age, American Society of Anesthesiologists (ASA) score and the number of cases of complicated appendicitis, operative time, length of hospital stay, and times of analgesics use. However, the proportion of early gas out (within POD #2) was significantly greater in the LA group (80% vs. 57%, P < 0.05), and postoperative complications were significantly lower in the LA group (7% vs. 32%, P < 0.01). The costs for the two groups were not significantly different.

Conclusion: A laparoscopic appendectomy is a safe and effective procedure in elderly patients and is not associated with any increase in morbidity. It can be recommended for routine use in treating elderly patients with appendicitis.

目的:阑尾切除术是老年患者最常见的急诊手术。随着老年人数量的增加,老年人急性阑尾炎的病例也在增加。为了了解腹腔镜阑尾切除术对老年阑尾炎患者的临床意义,我们对60岁以上高龄阑尾炎患者行腹腔镜阑尾切除术的结果进行了调查,并与开放式手术的结果进行了比较。方法:我们回顾性研究了2007年7月至2009年12月期间60岁以上的阑尾炎患者,他们采用腹腔镜(LA)或开放式(OA)技术进行阑尾切除术。LA组30例,OA组47例。评估了人口统计数据、手术时间、住院时间、肠蠕动、疼痛控制、费用、并发症和既往疾病。结果:LA组与OA组在既往病史、性别、年龄、美国麻醉医师协会(ASA)评分、复杂性阑尾炎例数、手术时间、住院时间、镇痛药使用次数等方面无显著差异。然而,LA组早期气体排出比例(POD #2内)明显高于LA组(80%比57%,P < 0.05), LA组术后并发症明显低于LA组(7%比32%,P < 0.01)。两组的成本没有显著差异。结论:腹腔镜阑尾切除术对老年患者是一种安全有效的手术,与发病率的增加无关。推荐常规应用于老年阑尾炎患者。
{"title":"Laparoscopic versus open appendectomy for appendicitis in elderly patients.","authors":"Hyun Nam Baek,&nbsp;Yong Hwan Jung,&nbsp;Yong Hee Hwang","doi":"10.3393/jksc.2011.27.5.241","DOIUrl":"https://doi.org/10.3393/jksc.2011.27.5.241","url":null,"abstract":"<p><strong>Purpose: </strong>The appendectomy is the most common emergent surgical procedure in elderly patients. The increasing number of elderly persons has been accompanied by an increase in the number of cases of acute appendicitis in the elderly. In order to understand the clinical significance of a laparoscopic appendectomy for elderly patients with appendicitis, we investigated the results of a laparoscopic appendectomy for treating patients over 60 years of age with appendicitis and compared them with the results for an open technique.</p><p><strong>Methods: </strong>We studied retrospectively patients over 60 years of age who underwent an appendectomy with either a laparoscopic (LA) or open (OA) technique for appendicitis between July 2007 and December 2009. There were 30 patients in the LA group and 47 patients in the OA group. The demographic data, operative time, length of the hospital stay, bowel movement, pain control, cost, complications and pre-existing disease were assessed.</p><p><strong>Results: </strong>There were no significant differences between the LA and the OA groups with respect to pre-existing diseases, gender, age, American Society of Anesthesiologists (ASA) score and the number of cases of complicated appendicitis, operative time, length of hospital stay, and times of analgesics use. However, the proportion of early gas out (within POD #2) was significantly greater in the LA group (80% vs. 57%, P < 0.05), and postoperative complications were significantly lower in the LA group (7% vs. 32%, P < 0.01). The costs for the two groups were not significantly different.</p><p><strong>Conclusion: </strong>A laparoscopic appendectomy is a safe and effective procedure in elderly patients and is not associated with any increase in morbidity. It can be recommended for routine use in treating elderly patients with appendicitis.</p>","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/97/0f/jksc-27-241.PMC3218128.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30271130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Correlation between Liver Metastases and the Level of PRL-3 mRNA Expression in Patients with Primary Colorectal Cancer. 原发性结直肠癌患者肝转移与PRL-3 mRNA表达水平的相关性
Pub Date : 2011-10-01 Epub Date: 2011-10-31 DOI: 10.3393/jksc.2011.27.5.231
Nam Won Kim, Chong Woo Chu, Tae Sung Ahn, Chang Jin Kim, Dong Jun Jung, Myoung Won Son, Sang Ho Bae, Moon Soo Lee, Chang Ho Kim, Moo Jun Baek

Purpose: Phosphatase of regenerating liver-3 (PRL-3) has been associated with metastasis promotion. However, clinical applications of this association have not yet been clearly demonstrated. In this study, we evaluated the relation of PRL-3 mRNA level in primary colorectal cancer to the corresponding stage and to other clinicopathologic factors.

Methods: Two hundred forty-five patients with histologically-proven colorectal cancer underwent surgery between January 2004 and December 2006. RNA was extracted and cDNA was prepared by using reverse transcription. Quantification of PRL-3 was done using a real-time polymerase chain reaction.

Results: Eighty-six cases with well-preserved specimens were enrolled: 53 males and 33 females. The mean age was 63.4 years. According to tumour node metastasis (TNM) stage of the American Joint Committee on Cancer (AJCC), stage I was 11 cases, stage II was 38 cases, stage III was 23 cases, and stage IV was 14 cases. Among stage IV cases, one case was combined with liver and lung metastases, and one case was combined with liver metastases and peritoneal dissemination. The remaining stage IV patients were combined with only liver metastases. There was a significant correlation in PRL-3 mRNA expression between primary colorectal cancer and corresponding tumor stage. PRL-3 mRNA expression was increased in the liver metastases cases. Lymphatic and vascular invasion were significantly related with PRL-3 mRNA levels.

Conclusion: Advanced stage prediction may be obtained by measuring the level of PRL-3 mRNA expression in primary colorectal cancer. Especially, the risk of liver metastases may be predicted by measuring the level of PRL-3 mRNA expression in primary colorectal cancer. Further study is required to confirm these preliminary results.

目的:再生肝磷酸酶-3 (PRL-3)与促进转移有关。然而,这种关联的临床应用尚未得到明确证明。在本研究中,我们评估了原发性结直肠癌中PRL-3 mRNA水平与相应分期及其他临床病理因素的关系。方法:2004年1月至2006年12月间,经组织学证实的结直肠癌患者共245例。提取RNA,反转录制备cDNA。PRL-3的定量采用实时聚合酶链反应。结果:86例标本保存完好,男53例,女33例。平均年龄63.4岁。根据美国癌症联合委员会(AJCC)的肿瘤淋巴结转移(TNM)分期,I期11例,II期38例,III期23例,IV期14例。IV期病例中合并肝、肺转移1例,合并肝转移及腹膜播散1例。其余IV期患者仅合并肝转移。PRL-3 mRNA的表达在原发性结直肠癌与相应肿瘤分期之间有显著相关性。PRL-3 mRNA在肝转移病例中表达升高。淋巴和血管浸润与PRL-3 mRNA水平显著相关。结论:通过测定原发性结直肠癌中prl - 3mrna的表达水平,可以预测结肠癌的晚期。特别是,通过检测原发性结直肠癌中PRL-3 mRNA的表达水平,可以预测肝转移的风险。需要进一步的研究来证实这些初步结果。
{"title":"Correlation between Liver Metastases and the Level of PRL-3 mRNA Expression in Patients with Primary Colorectal Cancer.","authors":"Nam Won Kim,&nbsp;Chong Woo Chu,&nbsp;Tae Sung Ahn,&nbsp;Chang Jin Kim,&nbsp;Dong Jun Jung,&nbsp;Myoung Won Son,&nbsp;Sang Ho Bae,&nbsp;Moon Soo Lee,&nbsp;Chang Ho Kim,&nbsp;Moo Jun Baek","doi":"10.3393/jksc.2011.27.5.231","DOIUrl":"https://doi.org/10.3393/jksc.2011.27.5.231","url":null,"abstract":"<p><strong>Purpose: </strong>Phosphatase of regenerating liver-3 (PRL-3) has been associated with metastasis promotion. However, clinical applications of this association have not yet been clearly demonstrated. In this study, we evaluated the relation of PRL-3 mRNA level in primary colorectal cancer to the corresponding stage and to other clinicopathologic factors.</p><p><strong>Methods: </strong>Two hundred forty-five patients with histologically-proven colorectal cancer underwent surgery between January 2004 and December 2006. RNA was extracted and cDNA was prepared by using reverse transcription. Quantification of PRL-3 was done using a real-time polymerase chain reaction.</p><p><strong>Results: </strong>Eighty-six cases with well-preserved specimens were enrolled: 53 males and 33 females. The mean age was 63.4 years. According to tumour node metastasis (TNM) stage of the American Joint Committee on Cancer (AJCC), stage I was 11 cases, stage II was 38 cases, stage III was 23 cases, and stage IV was 14 cases. Among stage IV cases, one case was combined with liver and lung metastases, and one case was combined with liver metastases and peritoneal dissemination. The remaining stage IV patients were combined with only liver metastases. There was a significant correlation in PRL-3 mRNA expression between primary colorectal cancer and corresponding tumor stage. PRL-3 mRNA expression was increased in the liver metastases cases. Lymphatic and vascular invasion were significantly related with PRL-3 mRNA levels.</p><p><strong>Conclusion: </strong>Advanced stage prediction may be obtained by measuring the level of PRL-3 mRNA expression in primary colorectal cancer. Especially, the risk of liver metastases may be predicted by measuring the level of PRL-3 mRNA expression in primary colorectal cancer. Further study is required to confirm these preliminary results.</p>","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6f/86/jksc-27-231.PMC3218126.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30271128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Prognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer. 淋巴结比例在III期直肠癌中的预后意义。
Pub Date : 2011-10-01 Epub Date: 2011-10-31 DOI: 10.3393/jksc.2011.27.5.252
Jin Yong Shin, Kwan Hee Hong

Purpose: Although nodal metastasis is the most powerful prognostic factor in rectal cancer, marked heterogeneity exists within stage III rectal cancer. Recent studies of rectal cancer have shown a prognostic superiority of the lymph node ratio (LNR) compared with N stage. The purpose of this study was to investigate the prognostic value of the LNR in the era of the 7th edition of the TNM classification.

Methods: We included 190 patients who underwent a curative resection for rectal cancer with nodal metastasis. The patients were divided into four groups on the basis of statistically calculated cut-off values as 0.21, 0.32, and 0.61.

Results: The LNR was an independent risk factor for overall survival (OS; P = 0.008) and for systemic recurrence-free survival (SRFS; P = 0.002). However, the LNR was not a predictive factor for local recurrence. When the N stage of the sixth TNM staging system was separately analyzed as a covariate, the LNR was also found to be a predictive factor for both OS and SRFS (P = 0.012 and P = 0.004, respectively). A LNR value of 0.21 offered the best cut off to separate patients into two prognostic groups.

Conclusion: The defined cut-off values of the LNR were an independent risk factor for OS and distant metastasis-free survival in patients with rectal cancer, irrespective of the sixth or the seventh version of the TNM classification, and the LNR should be considered as a prognostic variable in any future staging system.

目的:虽然结转移是直肠癌最重要的预后因素,但在III期直肠癌中存在明显的异质性。最近的直肠癌研究表明,淋巴结比例(LNR)与N期相比具有预后优势。本研究的目的是探讨LNR在TNM分类第7版时代的预后价值。方法:我们纳入190例接受根治性直肠癌结转移切除术的患者。根据统计计算的临界值0.21、0.32、0.61将患者分为四组。结果:LNR是总生存期(OS;P = 0.008)和全身无复发生存期(SRFS;P = 0.002)。然而,LNR并不是局部复发的预测因素。当第6 TNM分期系统的N期作为协变量单独分析时,LNR也被发现是OS和SRFS的预测因素(P = 0.012和P = 0.004分别)。LNR值为0.21提供了将患者分为两个预后组的最佳截断值。结论:LNR的定义临界值是直肠癌患者OS和无远处转移生存的独立危险因素,无论TNM的第六版还是第七版,LNR都应被视为未来任何分期系统的预后变量。
{"title":"Prognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer.","authors":"Jin Yong Shin,&nbsp;Kwan Hee Hong","doi":"10.3393/jksc.2011.27.5.252","DOIUrl":"https://doi.org/10.3393/jksc.2011.27.5.252","url":null,"abstract":"<p><strong>Purpose: </strong>Although nodal metastasis is the most powerful prognostic factor in rectal cancer, marked heterogeneity exists within stage III rectal cancer. Recent studies of rectal cancer have shown a prognostic superiority of the lymph node ratio (LNR) compared with N stage. The purpose of this study was to investigate the prognostic value of the LNR in the era of the 7th edition of the TNM classification.</p><p><strong>Methods: </strong>We included 190 patients who underwent a curative resection for rectal cancer with nodal metastasis. The patients were divided into four groups on the basis of statistically calculated cut-off values as 0.21, 0.32, and 0.61.</p><p><strong>Results: </strong>The LNR was an independent risk factor for overall survival (OS; P = 0.008) and for systemic recurrence-free survival (SRFS; P = 0.002). However, the LNR was not a predictive factor for local recurrence. When the N stage of the sixth TNM staging system was separately analyzed as a covariate, the LNR was also found to be a predictive factor for both OS and SRFS (P = 0.012 and P = 0.004, respectively). A LNR value of 0.21 offered the best cut off to separate patients into two prognostic groups.</p><p><strong>Conclusion: </strong>The defined cut-off values of the LNR were an independent risk factor for OS and distant metastasis-free survival in patients with rectal cancer, irrespective of the sixth or the seventh version of the TNM classification, and the LNR should be considered as a prognostic variable in any future staging system.</p>","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/da/56/jksc-27-252.PMC3218130.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30271132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Is There Any Relationship between the Chronicity of Chronic Anal Fissure and Endothelin-1? 慢性肛裂的慢性性与内皮素-1有关系吗?
Pub Date : 2011-10-01 Epub Date: 2011-10-31 DOI: 10.3393/jksc.2011.27.5.221
Won-Kyung Kang
{"title":"Is There Any Relationship between the Chronicity of Chronic Anal Fissure and Endothelin-1?","authors":"Won-Kyung Kang","doi":"10.3393/jksc.2011.27.5.221","DOIUrl":"https://doi.org/10.3393/jksc.2011.27.5.221","url":null,"abstract":"","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/7a/jksc-27-221.PMC3218122.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30271123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Lymph node ratio for nodal staging in colorectal cancer - a promising, but premature tool. 结直肠癌淋巴结分期的淋巴结比例-一个有前途但不成熟的工具。
Pub Date : 2011-10-01 Epub Date: 2011-10-31 DOI: 10.3393/jksc.2011.27.5.224
Kang Young Lee
See Article on Page 252-265 Accurate tumor staging is an essential step for the management of colorectal cancer patients. Precise tumor staging has a pivotal role not only for the prediction of the patient's prognosis, but also for the selection of patients for adjuvant therapy. The Tumor-node-metastasis (TNM) staging system based on pathologic findings is the most popular staging system in clinical practice. Among several prognosticators in TNM staging, the presence of regional lymph-node metastasis is the most potent indicator of the patient's prognosis in cases of colorectal cancer. In the current staging system, nodal stage is classified by the number of metastatic lymph nodes. In addition, several studies have reported that the number of retrieved lymph nodes also has prognostic power because a sufficient number of lymph nodes should be examined for accurate staging. For that reason, in the American Joint Committee on Cancer (AJCC) 7th edition recommends that at least 10-14 lymph nodes in radical colon and rectum resections should be examined for reliable nodal staging [1]. The number of retrieved lymph nodes could be affected by the extent of surgery and the pertinacity of the pathologist, but the location of tumor, the application of preoperative radiotherapy, and patient factors, including body mass index, could also be contributing factors. Moreover, in cases of preoperative chemoradiation therapy, the proportion of those with fewer than 12 examined lymph nodes may be increased. Since a prerequisite for the current nodal staging is the examination of over 10-14 regional lymph nodes, nodal staging in stage III colorectal cancer, which is solely based on the number of metastatic lymph nodes, would be inaccurate in certain circumstances. Recently, the metastatic lymph-node ratio has been suggested as an alternative tool for nodal staging in stage III colorectal cancer [2-4]. Also, after preoperative chemoradiation therapy in rectal cancer patients, the lymph-node ratio has reportedly been able to provide better stratification of patients' prognoses than ypN staging [5]. A recent series of publications support the lymph-node ratio's being a successful substitute for the current nodal staging in overcoming the limitation of the numeric counting system in cases of colorectal cancer. However, there are still several problems in the studies regarding the lymph-node ratio. The biggest hurdle in nodal staging with the lymph-node ratio may be that there is no consensus on a point of reference for stratification. Even though the lymph-node ratio has shown very nice stratification of patients' prognoses in cases of stage III colorectal cancer, not all studies adapted the same point of reference. Standardization of the point of reference would be an essential step toward use of the lymph-node ratio in staging. There is no doubt that precise lymph-node staging would be an essential step toward providing accurate prognoses for colorectal
{"title":"Lymph node ratio for nodal staging in colorectal cancer - a promising, but premature tool.","authors":"Kang Young Lee","doi":"10.3393/jksc.2011.27.5.224","DOIUrl":"https://doi.org/10.3393/jksc.2011.27.5.224","url":null,"abstract":"See Article on Page 252-265 \u0000 \u0000Accurate tumor staging is an essential step for the management of colorectal cancer patients. Precise tumor staging has a pivotal role not only for the prediction of the patient's prognosis, but also for the selection of patients for adjuvant therapy. The Tumor-node-metastasis (TNM) staging system based on pathologic findings is the most popular staging system in clinical practice. \u0000 \u0000Among several prognosticators in TNM staging, the presence of regional lymph-node metastasis is the most potent indicator of the patient's prognosis in cases of colorectal cancer. In the current staging system, nodal stage is classified by the number of metastatic lymph nodes. In addition, several studies have reported that the number of retrieved lymph nodes also has prognostic power because a sufficient number of lymph nodes should be examined for accurate staging. For that reason, in the American Joint Committee on Cancer (AJCC) 7th edition recommends that at least 10-14 lymph nodes in radical colon and rectum resections should be examined for reliable nodal staging [1]. \u0000 \u0000The number of retrieved lymph nodes could be affected by the extent of surgery and the pertinacity of the pathologist, but the location of tumor, the application of preoperative radiotherapy, and patient factors, including body mass index, could also be contributing factors. Moreover, in cases of preoperative chemoradiation therapy, the proportion of those with fewer than 12 examined lymph nodes may be increased. Since a prerequisite for the current nodal staging is the examination of over 10-14 regional lymph nodes, nodal staging in stage III colorectal cancer, which is solely based on the number of metastatic lymph nodes, would be inaccurate in certain circumstances. \u0000 \u0000Recently, the metastatic lymph-node ratio has been suggested as an alternative tool for nodal staging in stage III colorectal cancer [2-4]. Also, after preoperative chemoradiation therapy in rectal cancer patients, the lymph-node ratio has reportedly been able to provide better stratification of patients' prognoses than ypN staging [5]. A recent series of publications support the lymph-node ratio's being a successful substitute for the current nodal staging in overcoming the limitation of the numeric counting system in cases of colorectal cancer. However, there are still several problems in the studies regarding the lymph-node ratio. \u0000 \u0000The biggest hurdle in nodal staging with the lymph-node ratio may be that there is no consensus on a point of reference for stratification. Even though the lymph-node ratio has shown very nice stratification of patients' prognoses in cases of stage III colorectal cancer, not all studies adapted the same point of reference. Standardization of the point of reference would be an essential step toward use of the lymph-node ratio in staging. There is no doubt that precise lymph-node staging would be an essential step toward providing accurate prognoses for colorectal ","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/0f/jksc-27-224.PMC3218124.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30271126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The synchronous prevalence of colorectal neoplasms in patients with stomach cancer. 胃癌患者结直肠肿瘤的同步患病率。
Pub Date : 2011-10-01 Epub Date: 2011-10-31 DOI: 10.3393/jksc.2011.27.5.246
Sang Su Lee, Woon Tae Jung, Cha Young Kim, Chang Yoon Ha, Hyun Ju Min, Hyun Jin Kim, Tae Hyo Kim

Purpose: The association between stomach cancer and colorectal cancer is controversial. The purpose of this study was to determine the synchronous prevalence of colorectal neoplasms in patients with stomach cancer.

Methods: A total of 123 patients with stomach cancer (86 male) and 246 consecutive, age- and sex-matched persons without stomach cancer were analyzed from July 2005 to June 2010. All of them underwent colonoscopy within 6 months after undergoing gastroscopy.

Results: The prevalence of colorectal neoplasms was significantly higher in the stomach cancer group (35.8%) than in the control group (17.9%) (P < 0.001). Colorectal neoplasms were more prevalent in the patients with stomach cancer (odds ratio [OR], 3.10; 95% confidence interval [CI], 1.71 to 5.63). In particular, the difference in the prevalence of colorectal neoplasms was more prominent in the patients above 50 years old (OR, 3.54; 95% CI, 1.80 to 6.98).

Conclusion: The results showed that the synchronous prevalence of colorectal neoplasms was higher in patients with stomach cancer than in those without stomach cancer. Therefore, patients with stomach cancer should be regarded as a high-risk group for colorectal neoplasms, and colonoscopy should be recommended for screening.

目的:胃癌与结直肠癌之间的关系尚存争议。本研究的目的是确定胃癌患者结直肠肿瘤的同步患病率。方法:对2005年7月至2010年6月我院收治的123例胃癌患者(男性86例)和246例年龄、性别匹配的连续非胃癌患者进行分析。所有患者均在胃镜检查后6个月内行结肠镜检查。结果:胃癌组结直肠肿瘤患病率(35.8%)明显高于对照组(17.9%),差异有统计学意义(P < 0.001)。结直肠肿瘤在胃癌患者中更为普遍(优势比[OR], 3.10;95%置信区间[CI], 1.71 ~ 5.63)。特别是在50岁以上的患者中,结直肠肿瘤患病率的差异更为突出(OR, 3.54;95% CI, 1.80 ~ 6.98)。结论:胃癌患者结直肠肿瘤同步患病率高于非胃癌患者。因此,胃癌患者应被视为结直肠肿瘤的高危人群,建议进行结肠镜检查筛查。
{"title":"The synchronous prevalence of colorectal neoplasms in patients with stomach cancer.","authors":"Sang Su Lee,&nbsp;Woon Tae Jung,&nbsp;Cha Young Kim,&nbsp;Chang Yoon Ha,&nbsp;Hyun Ju Min,&nbsp;Hyun Jin Kim,&nbsp;Tae Hyo Kim","doi":"10.3393/jksc.2011.27.5.246","DOIUrl":"https://doi.org/10.3393/jksc.2011.27.5.246","url":null,"abstract":"<p><strong>Purpose: </strong>The association between stomach cancer and colorectal cancer is controversial. The purpose of this study was to determine the synchronous prevalence of colorectal neoplasms in patients with stomach cancer.</p><p><strong>Methods: </strong>A total of 123 patients with stomach cancer (86 male) and 246 consecutive, age- and sex-matched persons without stomach cancer were analyzed from July 2005 to June 2010. All of them underwent colonoscopy within 6 months after undergoing gastroscopy.</p><p><strong>Results: </strong>The prevalence of colorectal neoplasms was significantly higher in the stomach cancer group (35.8%) than in the control group (17.9%) (P < 0.001). Colorectal neoplasms were more prevalent in the patients with stomach cancer (odds ratio [OR], 3.10; 95% confidence interval [CI], 1.71 to 5.63). In particular, the difference in the prevalence of colorectal neoplasms was more prominent in the patients above 50 years old (OR, 3.54; 95% CI, 1.80 to 6.98).</p><p><strong>Conclusion: </strong>The results showed that the synchronous prevalence of colorectal neoplasms was higher in patients with stomach cancer than in those without stomach cancer. Therefore, patients with stomach cancer should be regarded as a high-risk group for colorectal neoplasms, and colonoscopy should be recommended for screening.</p>","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b4/38/jksc-27-246.PMC3218129.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30271131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Is There Any Relationship between the Chronicity of Chronic Anal Fissure and Endothelin-1? 慢性肛裂的慢性性与内皮素-1有关系吗?
Pub Date : 2011-10-01 Epub Date: 2011-10-31 DOI: 10.3393/jksc.2011.27.5.237
Cheong Ho Lim, Hyeon Keun Shin, Wook Ho Kang, Seung Kyu Jeong, Hyung Kyu Yang

Purpose: Many kinds of substances are produced on vascular endothelial activation. The aim of this study is to confirm an increase in Endothelin-1 (ET-1), the most potent vasoconstrictor, which is produced by endothelial activation, in patients with chronic anal fissure and to infer the relationship between ET-1 and anal fissure chronicity.

Methods: The study groups are divided into three different groups with 30 subjects each. Group 1 is comprised of healthy volunteers, group 2 of chronic anal fissure patients, and Group 3 of patients with higher than 3rd degree hemorrhoids. Blood samples were taken to measure the ET-1 levels in subject's serum and to compare the results with those for the control groups.

Results: Among the 90 subjects, 38 were male, and 52 were female. The average age was 36.8. The average ET-1 level marked 1.47 ± 0.78 pg/mL for male subjects and 1.16 ± 0.47 pg/mL for female subjects (P = 0.02). The average ET-1 level in the patient groups is as follow: 1.21 ± 0.44 pg/mL in group 1, 1.46 ± 0.83 pg/mL in group 2, and 1.20 ± 0.56 pg/mL in group 3 (P = 0.14).

Conclusion: Group 2, the chronic anal fissure patient group, showed a higher ET-1 level than groups 1 and 3, the control group and the hemorrhoid patient group, but this difference had no statistical significance.

目的:血管内皮活化产生多种物质。本研究的目的是证实内皮素-1 (ET-1)的增加,内皮素-1是由内皮细胞激活产生的最有效的血管收缩剂,在慢性肛裂患者中,并推断ET-1与肛裂慢性之间的关系。方法:将研究对象分为三组,每组30人。第一组为健康志愿者,第二组为慢性肛裂患者,第三组为三度以上痔疮患者。取血检测受试者血清中ET-1水平,并与对照组进行比较。结果:90例受试者中,男性38例,女性52例。平均年龄为36.8岁。男性受试者ET-1平均水平为1.47±0.78 pg/mL,女性受试者ET-1平均水平为1.16±0.47 pg/mL (P = 0.02)。各组平均ET-1水平:1组为1.21±0.44 pg/mL, 2组为1.46±0.83 pg/mL, 3组为1.20±0.56 pg/mL (P = 0.14)。结论:组2慢性肛裂患者组ET-1水平高于组1、组3对照组和痔疮患者组,但差异无统计学意义。
{"title":"Is There Any Relationship between the Chronicity of Chronic Anal Fissure and Endothelin-1?","authors":"Cheong Ho Lim,&nbsp;Hyeon Keun Shin,&nbsp;Wook Ho Kang,&nbsp;Seung Kyu Jeong,&nbsp;Hyung Kyu Yang","doi":"10.3393/jksc.2011.27.5.237","DOIUrl":"https://doi.org/10.3393/jksc.2011.27.5.237","url":null,"abstract":"<p><strong>Purpose: </strong>Many kinds of substances are produced on vascular endothelial activation. The aim of this study is to confirm an increase in Endothelin-1 (ET-1), the most potent vasoconstrictor, which is produced by endothelial activation, in patients with chronic anal fissure and to infer the relationship between ET-1 and anal fissure chronicity.</p><p><strong>Methods: </strong>The study groups are divided into three different groups with 30 subjects each. Group 1 is comprised of healthy volunteers, group 2 of chronic anal fissure patients, and Group 3 of patients with higher than 3rd degree hemorrhoids. Blood samples were taken to measure the ET-1 levels in subject's serum and to compare the results with those for the control groups.</p><p><strong>Results: </strong>Among the 90 subjects, 38 were male, and 52 were female. The average age was 36.8. The average ET-1 level marked 1.47 ± 0.78 pg/mL for male subjects and 1.16 ± 0.47 pg/mL for female subjects (P = 0.02). The average ET-1 level in the patient groups is as follow: 1.21 ± 0.44 pg/mL in group 1, 1.46 ± 0.83 pg/mL in group 2, and 1.20 ± 0.56 pg/mL in group 3 (P = 0.14).</p><p><strong>Conclusion: </strong>Group 2, the chronic anal fissure patient group, showed a higher ET-1 level than groups 1 and 3, the control group and the hemorrhoid patient group, but this difference had no statistical significance.</p>","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/ea/jksc-27-237.PMC3218127.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30271129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Colorectal cancer with multiple metastases: is palliative surgery needed? 结直肠癌多发转移:是否需要姑息性手术?
Pub Date : 2011-10-01 Epub Date: 2011-10-31 DOI: 10.3393/jksc.2011.27.5.226
Hong-Jo Choi, Jin Yong Shin

In patients with symptomatic incurable metastatic colorectal cancer (mCRC), the goal of resection of the primary lesion is to palliate cancer-related morbidity, including obstruction, bleeding, or perforation. In patients with asymptomatic primary tumors and incurable metastatic disease, however, the necessity of primary tumor resection is less clear. Although several retrospective analyses suggest survival benefit in patients who undergo resection of the primary tumor, applying this older evidence to modern patients is out of date for several reasons. Modern chemotherapy regimens incorporating the novel cytotoxic agents oxaliplatin and irinotecan, as well as the target agents bevacizumab and cetuximab, have improved median survival from less than 1 year with the only available single-agent 5-fluorouracil until the mid-1990s to over 2 years. In addition to significant prolongation of overall survival, combinations of novel chemotherapeutic and target agents have allowed improved local and distant tumor control, decreasing the likelihood of local tumor-related complications requiring surgical resection. Resection of an asymptomatic primary tumor risks surgical complications and may postpone the administration of chemotherapy that may offer both systemic and local control. In conclusion, the morbidity and the mortality of unnecessary surgery or surgery that does not improve quality of life or survival in patients with mCRC of a limited life expectancy should be carefully evaluated. With the availability of effective combinations of chemotherapy and target agents, systemic therapy for the treatment of life-threatening metastases would be a preferable treatment strategy for unresectable asymptomatic patients with mCRC.

在有症状的无法治愈的转移性结直肠癌(mCRC)患者中,切除原发病变的目的是缓解癌症相关的发病率,包括梗阻、出血或穿孔。然而,对于无症状原发肿瘤和无法治愈的转移性肿瘤患者,原发肿瘤切除的必要性尚不明确。尽管一些回顾性分析表明,切除原发肿瘤对患者的生存有好处,但由于一些原因,将这一古老的证据应用于现代患者是过时的。现代化疗方案包括新型细胞毒性药物奥沙利铂和伊立替康,以及靶向药物贝伐单抗和西妥昔单抗,已将中位生存期从20世纪90年代中期唯一可用的单药5-氟尿嘧啶的不到1年提高到2年以上。除了显著延长总生存期外,新型化疗药物和靶向药物的联合使用还改善了局部和远处肿瘤的控制,降低了需要手术切除的局部肿瘤相关并发症的可能性。切除无症状的原发肿瘤有手术并发症的风险,并可能推迟化疗的实施,而化疗可能同时提供全身和局部控制。总之,对于预期寿命有限的mCRC患者,不必要的手术或不能改善生活质量或生存的手术的发病率和死亡率应仔细评估。随着化疗和靶向药物有效联合的可用性,对危及生命的转移瘤进行全身治疗将是不可切除的无症状mCRC患者的首选治疗策略。
{"title":"Colorectal cancer with multiple metastases: is palliative surgery needed?","authors":"Hong-Jo Choi,&nbsp;Jin Yong Shin","doi":"10.3393/jksc.2011.27.5.226","DOIUrl":"https://doi.org/10.3393/jksc.2011.27.5.226","url":null,"abstract":"<p><p>In patients with symptomatic incurable metastatic colorectal cancer (mCRC), the goal of resection of the primary lesion is to palliate cancer-related morbidity, including obstruction, bleeding, or perforation. In patients with asymptomatic primary tumors and incurable metastatic disease, however, the necessity of primary tumor resection is less clear. Although several retrospective analyses suggest survival benefit in patients who undergo resection of the primary tumor, applying this older evidence to modern patients is out of date for several reasons. Modern chemotherapy regimens incorporating the novel cytotoxic agents oxaliplatin and irinotecan, as well as the target agents bevacizumab and cetuximab, have improved median survival from less than 1 year with the only available single-agent 5-fluorouracil until the mid-1990s to over 2 years. In addition to significant prolongation of overall survival, combinations of novel chemotherapeutic and target agents have allowed improved local and distant tumor control, decreasing the likelihood of local tumor-related complications requiring surgical resection. Resection of an asymptomatic primary tumor risks surgical complications and may postpone the administration of chemotherapy that may offer both systemic and local control. In conclusion, the morbidity and the mortality of unnecessary surgery or surgery that does not improve quality of life or survival in patients with mCRC of a limited life expectancy should be carefully evaluated. With the availability of effective combinations of chemotherapy and target agents, systemic therapy for the treatment of life-threatening metastases would be a preferable treatment strategy for unresectable asymptomatic patients with mCRC.</p>","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/ce/jksc-27-226.PMC3218125.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30271127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer. 结直肠癌III期淋巴结比例的临床意义。
Pub Date : 2011-10-01 Epub Date: 2011-10-31 DOI: 10.3393/jksc.2011.27.5.260
Yo Han Park, Jae Im Lee, Jong Kyung Park, Hang Ju Jo, Won Kyung Kang, Chang Hyeok An

Purpose: Recent literature has shown that lymph node ratio is superior to the absolute number of metastatic lymph nodes in predicting the prognosis in several malignances other than colorectal cancer. The aim of this study was to evaluate the prognostic significance of the lymph node ratio (LNR) in patients with stage III colorectal cancer.

Methods: We included 186 stage III colorectal cancer patients who underwent a curative resection over a 10-year period in one hospital. The cutoff point of LNR was chosen as 0.07 because there was significant survival difference at that LNR. The Kaplan-Meier and the Cox proportional hazard models were used to evaluate the prognostic effect according to LNR.

Results: There was statistically significant longer overall survival in the group of LNR > 0.07 than in the group of LNR ≤ 7 (P = 0.008). Especially, there was a survival difference for the N1 patients group (LN < 4) according to LNR (5-year survival of N1 patients was lower in the group of LNR > 0.07, P = 0.025), but there was no survival difference for the N2 group (4 ≥ LN) according to LNR. The multivariate analysis showed that the LNR is an independent prognostic factor.

Conclusions: LNR can be considered as a more accurate and potent modality for prognostic stratifications in patients with stage III colorectal cancer.

目的:近期文献显示,在预测除结直肠癌以外的几种恶性肿瘤的预后时,淋巴结比例优于转移淋巴结的绝对数量。本研究的目的是评估淋巴结比例(LNR)在III期结直肠癌患者中的预后意义。方法:我们纳入186例在一家医院接受10年治愈性切除的III期结直肠癌患者。LNR的临界值为0.07,因为在该LNR处存在显著的生存差异。根据LNR采用Kaplan-Meier和Cox比例风险模型评价预后效果。结果:LNR > 0.07组总生存期长于LNR≤7组,差异有统计学意义(P = 0.008)。其中N1组(LN < 4)按LNR有生存差异(LNR > 0.07组N1患者5年生存率较低,P = 0.025), N2组(4≥LN)按LNR无生存差异。多因素分析显示LNR是一个独立的预后因素。结论:LNR可被认为是III期结直肠癌患者预后分层的更准确和有效的方式。
{"title":"Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer.","authors":"Yo Han Park,&nbsp;Jae Im Lee,&nbsp;Jong Kyung Park,&nbsp;Hang Ju Jo,&nbsp;Won Kyung Kang,&nbsp;Chang Hyeok An","doi":"10.3393/jksc.2011.27.5.260","DOIUrl":"https://doi.org/10.3393/jksc.2011.27.5.260","url":null,"abstract":"<p><strong>Purpose: </strong>Recent literature has shown that lymph node ratio is superior to the absolute number of metastatic lymph nodes in predicting the prognosis in several malignances other than colorectal cancer. The aim of this study was to evaluate the prognostic significance of the lymph node ratio (LNR) in patients with stage III colorectal cancer.</p><p><strong>Methods: </strong>We included 186 stage III colorectal cancer patients who underwent a curative resection over a 10-year period in one hospital. The cutoff point of LNR was chosen as 0.07 because there was significant survival difference at that LNR. The Kaplan-Meier and the Cox proportional hazard models were used to evaluate the prognostic effect according to LNR.</p><p><strong>Results: </strong>There was statistically significant longer overall survival in the group of LNR > 0.07 than in the group of LNR ≤ 7 (P = 0.008). Especially, there was a survival difference for the N1 patients group (LN < 4) according to LNR (5-year survival of N1 patients was lower in the group of LNR > 0.07, P = 0.025), but there was no survival difference for the N2 group (4 ≥ LN) according to LNR. The multivariate analysis showed that the LNR is an independent prognostic factor.</p><p><strong>Conclusions: </strong>LNR can be considered as a more accurate and potent modality for prognostic stratifications in patients with stage III colorectal cancer.</p>","PeriodicalId":17346,"journal":{"name":"Journal of the Korean Society of Coloproctology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e3/1f/jksc-27-260.PMC3218131.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30268464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Journal of the Korean Society of Coloproctology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1